NWRD08
/ Newish Technology
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
February 18, 2026
Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL
(clinicaltrials.gov)
- P2 | N=150 | Recruiting | Sponsor: Newish Biotech (Wuxi) Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open
September 17, 2025
Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL
(clinicaltrials.gov)
- P2 | N=150 | Not yet recruiting | Sponsor: Newish Biotech (Wuxi) Co., Ltd.
New P2 trial
February 23, 2024
NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL
(clinicaltrials.gov)
- P1 | N=9 | Recruiting | Sponsor: Newish Technology (Beijing) Co., Ltd.
New P1 trial
June 15, 2023
Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive
(clinicaltrials.gov)
- P=N/A | N=12 | Recruiting | Sponsor: Newish Technology (Beijing) Co., Ltd.
New trial
1 to 4
Of
4
Go to page
1